Discontinuation of Nucleos(t)ide Analog treatment in HBeAg-Negative Non-Cirrhotic Chronic Hepatitis B Patients: Real-Life Data of 20 Years

CONCLUSION: In resource-limited areas where follow-up of HBsAg or other markers is not possible, nucleos(t)ide analog discontinuation can be considered in patients in the early stage, with low baseline hepatitis B virus DNA and ALT levels, after a long consolidation therapy.PMID:37681268 | DOI:10.5152/tjg.2023.22823

Source: The Turkish Journal of Gastroenterology - September 8, 2023 Category: Gastroenterology Authors: Bilg ül Mete Sibel Y ıldız Kaya Abdurrahman Kaya Ahmet Furkan Kurt Osman Faruk Bayramlar R ıdvan Karaali İlker İnanç Balkan M ücahit Yemişen Re şat Özaras Ne şe Saltoğlu Fehmi Tabak Source Type: research